Literature DB >> 7548332

Cardiac iron overload in thalassemic patients: an endomyocardial biopsy study.

T Lombardo1, C Tamburino, G Bartoloni, M L Morrone, V Frontini, F Italia, S Cordaro, A Privitera, V Calvi.   

Abstract

Secondary heart failure induced by organ siderosis is the main cause of death in patients affected by thalassemia major. At present it cannot be predicted whether heart siderosis is correlated with iron overload and little is known about the real cardiac histological pattern of post transfusional hemochromatosis in patients with thalassemia major and intermedia. The study aim was to evaluate cardiac iron overload by non invasive and invasive techniques. Fifteen thalassemic patients were investigated and endomyocardial biopsy performed in ten revealed different grades of endomyocardial iron overload with histochemical positivity. Non invasive techniques are not able to furnish an exact picture of the cardiac hemochromatosis. There was a significant correlation between serum ferritin and myocardial iron grade. Patients with elevated ferritin levels and poor compliance to chelating therapy are at high risk of severe heart hemochromatosis. It was seen that endomyocardial biopsy is a useful tool in studying myocardial iron.

Entities:  

Mesh:

Year:  1995        PMID: 7548332     DOI: 10.1007/bf01702649

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  27 in total

1.  [The value of nuclear magnetic resonance in the study of iron overload in thalassemia patients].

Authors:  H Perrimond; C Chagnon; I Moulanier; G Michel; H Guidicelli; P J Bernard
Journal:  Ann Pediatr (Paris)       Date:  1991-03

Review 2.  Clinical merit of endomyocardial biopsy.

Authors:  J W Mason; J B O'Connell
Journal:  Circulation       Date:  1989-05       Impact factor: 29.690

3.  Myocardial iron grading by endomyocardial biopsy. A clinico-pathologic study on iron overloaded patients.

Authors:  G Barosi; E Arbustini; A Gavazzi; M Grasso; A Pucci
Journal:  Eur J Haematol       Date:  1989-04       Impact factor: 2.997

4.  Iron absorption and loading in beta-thalassaemia intermedia.

Authors:  M J Pippard; S T Callender; G T Warner; D J Weatherall
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

Review 5.  Management of iron overload in the pediatric patient.

Authors:  A Cohen
Journal:  Hematol Oncol Clin North Am       Date:  1987-09       Impact factor: 3.722

6.  High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation.

Authors:  M A Aldouri; B Wonke; A V Hoffbrand; D M Flynn; S E Ward; J E Agnew; A J Hilson
Journal:  Acta Haematol       Date:  1990       Impact factor: 2.195

7.  Cross-sectional echocardiography. II. Analysis of mathematic models for quantifying volume of the formalin-fixed left ventricle.

Authors:  H L Wyatt; M K Heng; S Meerbaum; P Gueret; J Hestenes; E Dula; E Corday
Journal:  Circulation       Date:  1980-06       Impact factor: 29.690

8.  Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. I: Morphological and morphometric aspects.

Authors:  U Baandrup; E G Olsen
Journal:  Br Heart J       Date:  1981-05

9.  Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium.

Authors:  D H Fitchett; D J Coltart; W A Littler; M J Leyland; T Trueman; D I Gozzard; T J Peters
Journal:  Cardiovasc Res       Date:  1980-12       Impact factor: 10.787

10.  Global and segmental left ventricular function in beta-thalassemia.

Authors:  D T Kremastinos; P K Toutouzas; G P Vyssoulis; C A Venetis; H P Vretou; D G Avgoustakis
Journal:  Cardiology       Date:  1985       Impact factor: 1.869

View more
  14 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 2.  An approach to endomyocardial biopsy interpretation.

Authors:  K S Cunningham; J P Veinot; J Butany
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

3.  Iron-loaded cardiac myocytes stimulate cardiac myofibroblast DNA synthesis.

Authors:  Ying Liu; Douglas M Templeton
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

4.  Heart failure and malignant ventricular tachyarrhythmias due to hereditary hemochromatosis with iron overload cardiomyopathy.

Authors:  A W Demant; A Schmiedel; R Büttner; T Lewalter; C Reichel
Journal:  Clin Res Cardiol       Date:  2007-08-20       Impact factor: 5.460

5.  Establishment of secondary iron overloaded mouse model: evaluation of cardiac function and analysis according to iron concentration.

Authors:  Se Na Moon; Ji Whan Han; Hui Seung Hwang; Mee Jeong Kim; Soon Ju Lee; Jae Young Lee; Chang Kyu Oh; Dae Chul Jeong
Journal:  Pediatr Cardiol       Date:  2011-06-09       Impact factor: 1.655

Review 6.  Cardiac complications in beta-thalassemia: From mice to men.

Authors:  Sirinart Kumfu; Suthat Fucharoen; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-09

Review 7.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

8.  Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population.

Authors:  Luca Antonio Felice Di Odoardo; Marianna Giuditta; Elena Cassinerio; Alberto Roghi; Patrizia Pedrotti; Marco Vicenzi; Veronica Maria Sciumbata; Maria Domenica Cappellini; Alberto Pierini
Journal:  Intern Emerg Med       Date:  2017-04-29       Impact factor: 3.397

9.  Iron metabolism in mice with partial frataxin deficiency.

Authors:  Manuela M Santos; Carlos J Miranda; Joanne E Levy; Lynne K Montross; Mireille Cossée; Jorge Sequeiros; Nancy Andrews; Michel Koenig; Massimo Pandolfo
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

10.  d-Propranolol protects against oxidative stress and progressive cardiac dysfunction in iron overloaded rats.

Authors:  Jay H Kramer; Christopher F Spurney; Micaela Iantorno; Constantine Tziros; Joanna J Chmielinska; I Tong Mak; William B Weglicki
Journal:  Can J Physiol Pharmacol       Date:  2012-08-22       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.